Point72 Asset Management L.P. Acquires 1,413,722 Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Point72 Asset Management L.P. lifted its holdings in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 105.3% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 2,756,122 shares of the biopharmaceutical company’s stock after purchasing an additional 1,413,722 shares during the period. Point72 Asset Management L.P. […]

Related Keywords

Wellington ,New Zealand General ,New Zealand ,Elizabeth Crowley ,Richardm Wright ,Dekabank Deutsche Girozentrale ,Wolfe Research ,Cantor Fitzgerald ,Nasdaq ,Wellington Management Group ,Celldex Therapeutics ,Celldex Therapeutics Inc ,Charles Schwab Investment Management Inc ,Celldex Therapeutics Company Profile ,Affinity Asset Advisors ,Free Report ,Financial Markets ,Management Group ,Schwab Investment Management ,Asset Advisors ,Get Free Report ,Visit Holdingschannel ,Celldex Therapeutics Daily ,